Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of NanoViricides, Inc.

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of NanoViricides, Inc. (“NanoViricides” or the “Company”) (NYSE MKT:NNVC) concerning possible violations of federal securities laws. The investigation is focused on the Company’s business, operations and financial performance.

NanoViricides is a nano-biopharmaceutical company, engaged in the discovery, development and commercialization of therapeutics for the treatment of viral infections. The investigation is related to a report published February 11, 2014, on Seekingalpha.com alleging that NanoViricides is a “House of Cards with -80% downside,” and “a vehicle designed specifically to enrich insiders.” The Seekingalpha.com report claims that a shareholder derivative complaint, Yidam, Ltd. v. Anil Diwan, et al., Case No. 1:13-cv-01777-RM-BNB, filed July 5, 2013, in the United States District Court for the District of Colorado, is a “must-read document,” which outlines numerous examples of certain NanoViricides managers “abusing shareholders and looting the company.”

If you purchased NanoViricides shares, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at [phone], Toll Free at [phone], or by email to [e-mail], or visit our website at www.howardsmithlaw.com.

Law Offices of Howard G. SmithHoward G. Smith, Esquire(215) 638-4847(888) [e-mail]